Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127107021 | 12710702 | 1 | I | 2010 | 20100720 | 20160902 | 20160902 | EXP | CA-UCBSA-015829 | UCB | 77.80 | YR | F | Y | 69.50000 | KG | 20160902 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127107021 | 12710702 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 2 WEEKS(QOW) | N | 54295 | 125160 | 400 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 127107021 | 12710702 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | NB. OF INTAKES:4 | N | 125160 | 400 | MG | SOLUTION FOR INJECTION | ||||||
| 127107021 | 12710702 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 10 MG WEEKLY | 0 | ||||||||||
| 127107021 | 12710702 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | UNK UNK, WEEKLY (QW) | 0 | /wk | |||||||||
| 127107021 | 12710702 | 5 | C | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1500 MG, 2X/DAY (BID) | 0 | 1500 | MG | BID | |||||||
| 127107021 | 12710702 | 6 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | 200 MG, 2X/DAY (BID) | 0 | 200 | MG | BID | |||||||
| 127107021 | 12710702 | 7 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | INHALE | N | U | 0 | BID | ||||||||
| 127107021 | 12710702 | 8 | C | SUPRAX | CEFIXIME | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127107021 | 12710702 | 1 | Rheumatoid arthritis |
| 127107021 | 12710702 | 3 | Rheumatoid arthritis |
| 127107021 | 12710702 | 5 | Rheumatoid arthritis |
| 127107021 | 12710702 | 6 | Rheumatoid arthritis |
| 127107021 | 12710702 | 7 | Sinusitis |
| 127107021 | 12710702 | 8 | Sinusitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127107021 | 12710702 | OT |
| 127107021 | 12710702 | LT |
| 127107021 | 12710702 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127107021 | 12710702 | Arthralgia | |
| 127107021 | 12710702 | Gait disturbance | |
| 127107021 | 12710702 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127107021 | 12710702 | 1 | 20100609 | 20100609 | 0 | |
| 127107021 | 12710702 | 2 | 201007 | 201009 | 0 | |
| 127107021 | 12710702 | 3 | 2009 | 0 | ||
| 127107021 | 12710702 | 4 | 20100727 | 0 | ||
| 127107021 | 12710702 | 7 | 201007 | 0 | ||
| 127107021 | 12710702 | 8 | 20100611 | 0 |